Novartis Investigative Site

Fridley, Minnesota 55432

We've found

1 trials

at this facility

This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Fridley, MN

Use our guide to learn which trials are right for you!